Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-234-3 | CAS number: 104-76-7
Specific investigations: other studies
Administrative data
Link to relevant study record(s)
Description of key information
Additional information
- Observations following the repeated administration of 2 -EH to rats and mice included increased liver weight, peroxisome proliferation, and changes (induction) of enzymes involved in Phase I and Phase II drug metabolism
- 2 -EH is a peroxisome proliferator in rodents (rats and mice), but not in other species including humans. This effect is therefore not relevant for the assessment of human health effects.
- 2 -EH is hepatotoxic. Impairment of the mitochondrial energy supply is the underlying toxic mechanism.
- Degeneration of testes and Sertoli cells were not associated with 2 -EH, but with MEHP, which is generated following the administration of DEHP.
- 2-EH administered to cells of mouse Leydig tumour cell line, MA-10, did not reveal any reduction of steroidogenic potential of the cells (no reduction of progesterone production or gene expression of key steroidogenic enzymes). Whereas DEHP, MEHP and 2-ethylhexanal significantly disrupt the steroidogenesis in MA-10 cells.
- 2 -EH was found to have an impact on maternal-embryonic zinc metabolism (decrease of embryonic Zn uptake).
Abstracts of specific studies which do not follow standard test procedures indicate:
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
